Anti-human STK4 antibody in study to determine the most suitable therapy for the STK4-deficiency-related disease
June, 2021 (Department of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey)
Serine-threonine kinase-4 (STK4) deficiency is an autosomal recessive combined immunodeficiency (CID).
Using our anti-human STK4 antibody and Westernblotting, this newly published study aimed to define clinical and laboratory features to improve the differential diagnosis and determine the most suitable therapy for the STK4-deficiency-related disease.
Image from Atlas Antibodies product page: Western blot analysis in Caco-2 cells transfected with control siRNA, target specific siRNA probe #1, using Anti-STK4 antibody. Remaining relative intensity is presented.
Article page: https://lnkd.in/djkRBFQ
All about our Anti-STK4 antibodies read here:https://lnkd.in/dwvdpNN